AI optics demand drives record revenue and capacity expansion
- AXTI’s bull case now rests on indium phosphide demand from AI data centers.
- Q2 2026 revenue hit a record $47.6 million, led by a surge in indium phosphide sales.
- The company signed major supply agreements with Casella, Coherent, and Lumentum, bringing in large prepayments.
- AXTI plans to more than triple its indium phosphide capacity by the end of 2026.
- The Tongmei subsidiary IPO has shifted to the Hong Kong Exchange, delaying its listing timeline.
AI demand meets capacity limits
AXTI is a critical supplier in a massive bottleneck. It makes compound semiconductor substrates, which are the base wafers that other companies build advanced chips and optical devices on. The current cycle is driven by indium phosphide, or InP, because it is required for high-speed optical links inside AI data centers.
The bull case is massively accelerating. Q2 2026 saw record revenue of $47.6 million, with InP contributing $30.7 million. Demand is vastly outpacing supply. To catch up, management plans to more than triple InP capacity by the end of 2026 and double it again in 2027. New long-term supply agreements with major players like Coherent, Casella, and Lumentum have brought in almost $48 million in cash prepayments to help fund this growth.
The bear case continues to center on geopolitical friction and execution. U.S.-bound InP export permits remain a headache, though management notes the process is becoming more regular. Furthermore, China now represents over 50 percent of revenue, which side-steps some export risk but concentrates geographic exposure. The delayed Tongmei IPO, now pivoting to Hong Kong, keeps regulatory uncertainty in the mix.
The next year depends on how well AXTI executes its sequential capacity doublings and triplings without sacrificing quality, while maintaining its gross margin expansion toward 50 percent.
Special wafers, hard supply chains
AXTI makes money by selling high-performance wafers made from specialty materials. These are not standard silicon wafers. They are used when speed, light handling, or power conversion matters more than low cost.
Quality is the moat. The company focuses on extremely low defect density, which helps customers get more working devices from each wafer. This is critical as optical chips get larger and harder to manufacture, driving Tier 1 optical module makers to partner directly with AXTI.
AXTI is heavily vertically integrated. It designs its own crystal growth furnaces and recently completed a $632.5 million capital raise to expand operations. Its raw material joint ventures provide supply line security, with subsidiary JinMei now directly refining high-purity indium.
This control helps, but it does not remove the main break points. If export permits lag, if tariffs stay high, or if the aggressive capacity ramp hurts yields, the growth story could stumble.
Where the wafers go
Indium phosphide
InP is the main growth driver for AI data centers. Q2 2026 revenue hit a record $30.7 million, backed by massive supply agreements.
Iron-doped InP
Iron-doped substrates make up a significant portion of the large-diameter InP mix, driving gross margins higher.
Gallium arsenide
GaAs is used in VCSELs and industrial robotics. It coexists with InP but faces severe U.S. export friction.
Germanium
Germanium substrates are the smallest segment, mainly used for satellite solar cells.
Raw materials
Consolidated raw material joint ventures supply materials to the industry. JinMei now refines high-purity indium directly.
6-inch InP development
AXTI is pushing toward 6-inch InP wafers to meet customer demands for larger die and better factory throughput.
Substrates carry the company
The structured product mix uses 2025 consolidated revenue from the Q1 2026 Form 10-Q, with substrates at 67 percent. However, Q2 2026 saw massive concentration, with indium phosphide alone generating $30.7 million of the $47.6 million total revenue. Geographically, China now accounts for over 50 percent of revenue.
What could break the story
Capacity ramp misses the demand window
High impact · Medium oddsAXTI plans to more than triple InP capacity by late 2026 and double it again in 2027. This is a massive operating challenge. If new furnaces take longer to qualify or yields drop, the company could miss its window to convert backlog into revenue.
U.S. export permits stay stuck
High impact · Medium oddsWhile China demand has surged to over 50 percent of revenue, U.S.-bound InP permits remain a headwind. Management sees more regularity in the process, but direct U.S. shipments are still restricted.
Tongmei IPO remains delayed
Medium impact · Medium oddsThe planned IPO for the Tongmei subsidiary has abandoned the STAR Market and shifted to the Hong Kong Exchange, which could take a year. This triggered a $49 million redemption right from PE investors, though they have currently waived it.
Tariffs keep pressure on costs
Medium impact · Medium oddsTariffs under Section 232 and Section 301 remain in effect despite relief from IEEPA-based tariffs earlier in 2026. These rules can still hurt customer pricing and demand.
China demand cools after the build-out
Medium impact · Medium oddsChina now represents over 50 percent of revenue. If domestic Chinese AI infrastructure spending slows, AXTI could be left with new capacity and weaker pricing power.
In one breath
What does AXT make?
AXT makes compound semiconductor substrates. These are wafers made from materials such as indium phosphide, gallium arsenide, and germanium, which customers use to build optical devices, sensors, power amplifiers, and satellite solar cells.
Why is AXTI linked to AI data centers?
AI data centers need faster optical connections to move huge amounts of data. Indium phosphide substrates can be used in the optical devices that make those high-speed links work.
What is the biggest risk for AXTI?
The biggest risk is export control friction between China and the U.S. U.S.-bound indium phosphide permits are still pending, though the company is finding some regularity in the process and selling more directly within China.
Why is valuation a concern?
The bull case now assumes flawless capacity expansion and margin growth from the AI cycle. If any of those slip, the stock has little room for error.
